Skip to main content
. 2019 Dec 12;7(3):1901293. doi: 10.1002/advs.201901293

Figure 7.

Figure 7

In vivo tumor inhibition of Bi2Se3/DOX@MPs. Relative a) tumor volumes and b) body weights of H22 tumor‐bearing BALB/c mice after different treating. c) Representative photos and average tumor weight of excised tumors 15 days after treatments. d) H&E staining (200 ×) of the tumor tissues after the indicated treatments.